Compounds > oseltamivir
Page last updated: 2024-08-24

oseltamivir and B-Cell Chronic Lymphocytic Leukemia

oseltamivir has been researched along with B-Cell Chronic Lymphocytic Leukemia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calistri, A; Del Vecchio, C; Franchin, E; Marini, G; Nicolè, S; Palù, G; Parolin, C; Salata, C; Sgarabotto, D; Solimbergo, E1
Fischer, TK; Franck, KT; Pedersen, SS; Trebbien, R; Vorborg, K1
Schutten, M; van den Berg, B; van der Vries, E1
Field, T; Greene, JN; Kharfan-Dabaja, MA; Richards, K; Sandin, R; Velez, A1

Other Studies

4 other study(ies) available for oseltamivir and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Antiviral treatment and virological monitoring of oseltamivir-resistant influenza virus A(H1N1)pdm09 in a patient with chronic B lymphocytic leukemia.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:7

    Topics: Aged; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Leukemia, Lymphocytic, Chronic, B-Cell; Oseltamivir; Pneumonia, Viral; Treatment Outcome; Virus Shedding; Zanamivir

2019
Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014.
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2017, Jan-19, Volume: 22, Issue:3

    Topics: Antiviral Agents; Denmark; Drug Resistance, Viral; Genotype; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Mutation; Neuraminidase; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Zanamivir

2017
Fatal oseltamivir-resistant influenza virus infection.
    The New England journal of medicine, 2008, Sep-04, Volume: 359, Issue:10

    Topics: Aged; Antiviral Agents; Drug Resistance, Viral; Fatal Outcome; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mutation; Opportunistic Infections; Oseltamivir

2008
Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population.
    International journal of hematology, 2010, Volume: 91, Issue:1

    Topics: Adult; Antiviral Agents; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Oseltamivir; Transplantation, Homologous

2010